VENOSTENT

We're a clinical-stage therapeutic medical device company that's developed finely-tuned, bioabsorbable wraps intended to improve outcomes for the 5 million vascular surgeries performed each year... We're developing a bioabsorbable perivascular wrap, SelfWrap, that goes around arteriovenous (AV) access sites at the time of AV creation surgery. The wrap is intended to improve the usability (i.e. maturation) and durability (i.e. patency) of these sites for chronic kidney disease (CKD) patients requiring hemodialysis. If successful, this could improve the quality of life for CKD patients requiring hemodialysis.

Also known as: VenoStent, Inc.

Primary location: Houston United States